587 related articles for article (PubMed ID: 33356248)
21. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
22. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland JM; Duncan M; Di Marzo V; Pertwee RG
Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
25. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
26. Differential Enantiomer-Specific Signaling of Cannabidiol at CB
Bosquez-Berger T; Wilson S; Iliopoulos-Tsoutsouvas C; Jiang S; Wager-Miller J; Nikas SP; Mackie KP; Makriyannis A; Straiker A
Mol Pharmacol; 2022 Dec; 102(6):259-268. PubMed ID: 36153039
[TBL] [Abstract][Full Text] [Related]
27. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
Nigro E; Formato M; Crescente G; Daniele A
Molecules; 2021 May; 26(9):. PubMed ID: 34063214
[No Abstract] [Full Text] [Related]
28. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
Millán-Guerrero RO; Isais-Millán S
Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
30. Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Linciano P; Citti C; Luongo L; Belardo C; Maione S; Vandelli MA; Forni F; Gigli G; Laganà A; Montone CM; Cannazza G
J Nat Prod; 2020 Jan; 83(1):88-98. PubMed ID: 31891265
[TBL] [Abstract][Full Text] [Related]
31. Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
Pollastro F; Caprioglio D; Marotta P; Moriello AS; De Petrocellis L; Taglialatela-Scafati O; Appendino G
J Nat Prod; 2018 Mar; 81(3):630-633. PubMed ID: 29240420
[TBL] [Abstract][Full Text] [Related]
32. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
[TBL] [Abstract][Full Text] [Related]
33. Cannabimimetic plants: are they new cannabinoidergic modulators?
Kumar A; Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Memo M; Mastinu A
Planta; 2019 Jun; 249(6):1681-1694. PubMed ID: 30877436
[TBL] [Abstract][Full Text] [Related]
34. Promoting cannabis products to pharmaceutical drugs.
Koltai H; Poulin P; Namdar D
Eur J Pharm Sci; 2019 Apr; 132():118-120. PubMed ID: 30851400
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol.
Ross HR; Napier I; Connor M
J Biol Chem; 2008 Jun; 283(23):16124-34. PubMed ID: 18390906
[TBL] [Abstract][Full Text] [Related]
36. Cannabis sativa: Much more beyond Δ
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
[TBL] [Abstract][Full Text] [Related]
37. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
[TBL] [Abstract][Full Text] [Related]
38. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.
Bonini SA; Premoli M; Tambaro S; Kumar A; Maccarinelli G; Memo M; Mastinu A
J Ethnopharmacol; 2018 Dec; 227():300-315. PubMed ID: 30205181
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE; Friedman D
Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
[TBL] [Abstract][Full Text] [Related]
40. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
